Can Cutaneous Leishmaniasis Cause Bilateral Inguinal Lymphadenopathy?
Yes, cutaneous leishmaniasis can cause bilateral inguinal lymphadenopathy, though this represents lymphatic dissemination of the infection and is documented in approximately 10-18% of cases.
Clinical Evidence for Lymph Node Involvement
Lymphadenopathy is a recognized manifestation of cutaneous leishmaniasis (CL), representing dissemination beyond the primary skin lesion. In a study of 643 patients with zoonotic CL due to Leishmania major, lymph node enlargement occurred in 10.26% of cases, with inguinal nodes involved in 18% of those with lymphadenopathy 1. Importantly, 12% of patients had involvement of two lymph node areas simultaneously, which could include bilateral inguinal presentation 1.
Characteristics of Leishmanial Lymphadenopathy
The affected lymph nodes typically present as:
- Solitary, firm, mobile, and nontender
- Only moderately enlarged
- Persistent beyond clinical healing of skin lesions 1
The lymphadenopathy can occur in several patterns:
- Regional drainage pattern: Most commonly draining the site of cutaneous lesion
- Epitrochlear nodes: Most frequent (68%)
- Inguinal nodes: 18% of cases with lymphadenopathy 1
- Multiple node groups: Can involve two areas simultaneously (12% of cases) 1
Temporal Relationship and Diagnostic Implications
Critically, lymphadenopathy may appear before the typical cutaneous ulcer develops. Research on L. braziliensis demonstrated that lymph node enlargement can be the initial or only manifestation of infection, with parasites cultivated from lymph nodes prior to any skin lesion appearing 2. In that series, 3 of 10 patients had lymphadenopathy that regressed without ever developing typical cutaneous ulcers 2.
Pathophysiology
The lymph node involvement represents true dissemination of the parasite from the dermis. Histopathologic examination reveals:
- Amastigotes present in lymph nodes (though may be sparse)
- Leishmanial antigen detectable even when organisms are not visualized 1
- Histiocytic granulomas with varying degrees of necrosis 3
In some cases, it may be the leishmanial antigen rather than viable parasites that disseminates and produces lymphadenitis 1.
Clinical Management Implications
When encountering bilateral inguinal lymphadenopathy in a patient from an endemic area:
- Actively search for cutaneous lesions, even small ones resembling insect bites, as they may be subtle or overlooked 3
- Consider CL even without visible skin lesions, as lymphadenopathy can precede or occur without typical ulceration 2
- Obtain lymph node biopsy if diagnosis unclear, as parasites can be cultured from nodes 2
- Check serology (IFAT or other antibody tests), which may be positive 3
Species-Specific Considerations
While the IDSA/ASTMH guidelines 4 emphasize that "large regional adenopathy" is a feature of complex CL requiring systemic therapy, they do not specifically address bilateral presentation. However, the presence of significant lymphadenopathy—particularly bilateral inguinal involvement—would classify the case as complex CL, mandating systemic treatment rather than local therapy.
For bilateral inguinal lymphadenopathy with CL, systemic therapy is indicated 4, with options including:
- Liposomal amphotericin B
- Miltefosine (FDA-approved for CL)
- Pentavalent antimonials
- Pentamidine
Common Pitfall
The major pitfall is dismissing lymphadenopathy as unrelated to CL or failing to consider CL when typical cutaneous ulcers are absent or minimal. Physicians examining patients from endemic areas must recognize that lymph node enlargement, even without typical ulceration, may indicate leishmanial infection and warrants investigation 2.